Resistance and intolerance to statins-Reference-Cited by-同舟云学术

Resistance and intolerance to statins

Published:2014-10 Issue:10 Volume:24 Page:1057-1066
ISSN:0939-4753
Container-title:Nutrition, Metabolism and Cardiovascular Diseases
language:en
Short-container-title:Nutrition, Metabolism and Cardiovascular Diseases

Author:

Reiner Ž.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Reference83 articles.

1. Dyslipidemias in the prevention of cardiovascular disease: risks and causality;Graham;Curr Cardiol Rep,2012

2. ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS);Reiner;Eur Heart J,2011

3. ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines;Stone;J Am Coll Cardiol,2013

4. Statins in the primary prevention of cardiovascular disease;Reiner;Nat Rev Cardiol,2013

5. Prevalence and types of persistent dyslipidemia in patients treated with statins;Reiner;Croat Med J,2013

Cited by 194 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PCSK9 inhibitors and inclisiran with or without statin therapy on incident muscle symptoms and creatine kinase: a systematic review and network meta-analysis;Frontiers in Cardiovascular Medicine;2024-07-08

2. Hypolipidemic effect and gut microbiota regulation of Gypenoside aglycones in rats fed a high-fat diet;Journal of Ethnopharmacology;2024-06

3. Lomitapide repurposing for treatment of malignancies: A promising direction;Heliyon;2024-06

4. Overcoming patient reluctance to statin intolerance;Polish Heart Journal;2024-05-31

5. Inclisiran: the preclinical discovery and development of a novel therapy for the treatment of atherosclerosis;Expert Opinion on Drug Discovery;2024-05-28